ArticleAging2020

Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer's disease: a pre-clinical study.

Valentina Cecarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.